The abscopal effect of radiation therapy
- PMID: 33726502
- DOI: 10.2217/fon-2020-0994
The abscopal effect of radiation therapy
Abstract
Radiation therapy (RT) in some cases results in a systemic anticancer response known as the abscopal effect. Multiple hypotheses support the role of immune activation initiated by RT-induced DNA damage. Optimal radiation dose is necessary to promote the cGAS-STING pathway in response to radiation and initiate an IFN-1 signaling cascade that promotes the maturation and migration of dendritic cells to facilitate antigen presentation and stimulation of cytotoxic T cells. T cells then exert a targeted response throughout the body at areas not subjected to RT. These effects are further augmented through the use of immunotherapeutic drugs resulting in increased T-cell activity. Tumor-infiltrating lymphocyte presence and TREX1, KPNA2 and p53 signal expression are being explored as prognostic biomarkers.
Keywords: abscopal effect; autologous tumor vaccine; immunotherapy; radiation therapy/radiotherapy; vaccines.
Similar articles
-
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.J Immunother Cancer. 2020 May;8(1):e000340. doi: 10.1136/jitc-2019-000340. J Immunother Cancer. 2020. PMID: 32461345 Free PMC article.
-
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.Nat Commun. 2017 Jun 9;8:15618. doi: 10.1038/ncomms15618. Nat Commun. 2017. PMID: 28598415 Free PMC article.
-
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint Inhibitors.AAPS J. 2020 Oct 14;22(6):132. doi: 10.1208/s12248-020-00514-4. AAPS J. 2020. PMID: 33057937 Review.
-
Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response.Clin Cancer Res. 2020 Aug 1;26(15):3901-3907. doi: 10.1158/1078-0432.CCR-19-1321. Epub 2020 Apr 24. Clin Cancer Res. 2020. PMID: 32332013 Free PMC article. Review.
-
TREX1 Cuts Down on Cancer Immunogenicity.Trends Cell Biol. 2017 Aug;27(8):543-545. doi: 10.1016/j.tcb.2017.06.001. Epub 2017 Jun 15. Trends Cell Biol. 2017. PMID: 28625463
Cited by
-
Abscopal effect of focused ultrasound combined immunotherapy in animal solid tumor model: a systematic reviews and meta-analysis.Front Immunol. 2024 Dec 13;15:1474343. doi: 10.3389/fimmu.2024.1474343. eCollection 2024. Front Immunol. 2024. PMID: 39735534 Free PMC article.
-
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC).ESMO Open. 2025 Jul 23;10(8):105508. doi: 10.1016/j.esmoop.2025.105508. Online ahead of print. ESMO Open. 2025. PMID: 40706222 Free PMC article.
-
The Changing Face of Lung Cancer: Oligometastatic Renal Metastasis Post Chemo-Immunotherapy Combination.Eur J Case Rep Intern Med. 2023 Jun 7;10(7):003908. doi: 10.12890/2023_003908. eCollection 2023. Eur J Case Rep Intern Med. 2023. PMID: 37455692 Free PMC article.
-
Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer.Curr Oncol. 2023 Mar 26;30(4):3672-3683. doi: 10.3390/curroncol30040279. Curr Oncol. 2023. PMID: 37185392 Free PMC article. Review.
-
The Proteogenomics of Prostate Cancer Radioresistance.Cancer Res Commun. 2024 Sep 1;4(9):2463-2479. doi: 10.1158/2767-9764.CRC-24-0292. Cancer Res Commun. 2024. PMID: 39166898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous